{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05514119",
            "orgStudyIdInfo": {
                "id": "22-007122"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation",
            "officialTitle": "Fenofibrate to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Liver Transplantation (FICsDCD)",
            "acronym": "FICsDCD",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "a-study-to-assess-the-role-of-fenofibrate-in-preventing-ischemic-cholangiopathy-after-liver-transplantation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ACTUAL"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-23",
            "studyFirstSubmitQcDate": "2022-08-23",
            "studyFirstPostDateStruct": {
                "date": "2022-08-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Channa R Jayasekera, MD, MSc",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety and effectiveness of a once-daily medication, fenofibrate (Lofibra), to prevent ischemic cholangiography (IC) in persons who were transplanted with livers donated after circulatory death (DCD).",
            "detailedDescription": "In this prospective pilot study, we aim to evaluate 1) the tolerability and safety, 2) the efficacy of 12 weeks once-daily fenofibrate in reducing IC incidence after DCD liver transplantation, 3) assess the association between serum markers of cholestasis and development of IC."
        },
        "conditionsModule": {
            "conditions": [
                "Liver Transplant"
            ],
            "keywords": [
                "Ischemic Cholangiography"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 148,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Recipients of DCD liver transplants",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects that have undergone transplant of a liver donation after circulatory death (DCD) in the last 21-35 days will receive a 12 week fenofibrate (Lofibra) for a duration of 12 weeks",
                    "interventionNames": [
                        "Drug: Fenofibrate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Fenofibrate",
                    "description": "160mg once daily orally for 12 weeks",
                    "armGroupLabels": [
                        "Recipients of DCD liver transplants"
                    ],
                    "otherNames": [
                        "Lofibra"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Tolerability of fenofibrate",
                    "description": "Proportion of subjects to discontinue fenofibrate due to adverse events",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Safety of fenofibrate",
                    "description": "Proportion of subjects with a new grade 3 or 4 adverse event",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Safety of fenofibrate",
                    "description": "Proportion of subjects with acute cellular rejection during fenofibrate treatment",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Safety of fenofibrate",
                    "description": "Mean change in calculated glomerular filtration rate before, during and after fenofibrate treatment",
                    "timeFrame": "Baseline, treatment weeks 4, 8, 12, and at 4 weeks after end of treatment"
                },
                {
                    "measure": "Safety of fenofibrate",
                    "description": "Proportion of subjects myopathy confirmed by serum creatine kinase elevation",
                    "timeFrame": "4 weeks after end of treatment"
                },
                {
                    "measure": "Efficacy of fenofibrate",
                    "description": "Proportion of subjects who develop IC compared with historical control group",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Serum biomarker association with development of IC",
                    "description": "Assess association of 5 serum biomarkers with development of IC",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have undergone Donation after Circulatory Death (DCD) liver transplantation (LT).\n* At least one serum alkaline phosphatase level \\>2.5x upper limit of normal between post-LT days 21-60 (inclusive).\n\nExclusion criteria:\n\n* LT performed for primary sclerosing cholangitis or primary biliary cholangitis.\n* Untreated hepatic artery compromise (e.g thrombosis, stenosis)\n* Untreated biliary anastomotic stricture or bile leak between days 0-60 after LT\n* Renal dysfunction defined as baseline glomerular filtration rate \\< 30 ml/min.\n* Previously known intolerance or allergy to fenofibrate.\n* Other clinically significant comorbid condition, including psychiatric conditions, which in the opinion of the study team, may interfere with patient treatment, safety, assessment, or compliance with the treatment.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Channa Jayasekera, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Arizona",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85254",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Latasha Bunkley",
                            "role": "CONTACT",
                            "phone": "480-792-5756",
                            "email": "Bunkley.Latasha@Mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007511",
                    "term": "Ischemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6845",
                    "name": "Death",
                    "relevance": "LOW"
                },
                {
                    "id": "M10543",
                    "name": "Ischemia",
                    "asFound": "Ischemic",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011345",
                    "term": "Fenofibrate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000960",
                    "term": "Hypolipidemic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000057847",
                    "term": "Lipid Regulating Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14218",
                    "name": "Fenofibrate",
                    "asFound": "Messaging",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                },
                {
                    "id": "M4278",
                    "name": "Hypolipidemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M28883",
                    "name": "Lipid Regulating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Lipd",
                    "name": "Lipid Regulating Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                }
            ]
        }
    },
    "hasResults": false
}